Tradestie Institutional Equity Comparison Engine
ARDX vs AVDL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AVDL Overall Edge
AVDL Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ARDX trades at 18.9x Forward P/E with -7.7% operating margin (+15.7% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, ARDX sits in BREAKDOWN (14th %ile IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
AVDL
ARDX 18.9x vs AVDL 28.8x Fwd P/E
Growth & Margin Winner
AVDL
Op Margin -7.7% vs 2.5% ยท YoY +15.7% vs +54.9%
Momentum & Technical Winner
AVDL
1Y -46.3% vs +138.1% ยท 52W Pos 3% vs 89%
Options & Structure Winner
AVDL
BREAKDOWN (14th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
ARDX
NASDAQ
Ardelyx, Inc.
Pharmaceutical Preparations
$2.99
-2.29% 1D
Market Cap
$769.2M
1M Return
-6.56%
1Y Return
-46.32%
Forward P/E
18.9x
Unified AI Score
57.7 / 100
HOLD
Tech 43.0
Fund 54.0
Flow 70.0
Mom 54.0
AVDL
NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap
$2.1B
1M Return
+0.65%
1Y Return
+138.06%
Forward P/E
28.8x
Unified AI Score
62.9 / 100
BUY
Tech 75.0
Fund 60.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ARDX -46.32%
AVDL +138.06%
Spread: +36.66 pp (ARDX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ARDX TTM Op. Margin: -7.7%
AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARDX vs AVDL. Trailing 12-month operating profitability (ARDX -7.7% vs AVDL 2.5%) and valuation multiples (ARDX 18.9x vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ARDX | AVDL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $769.2M | $2.1B | Larger Scale | AVDL |
| Trailing P/E Ratio Valuation | 52.1x | 16.8x | Lower Multiple | AVDL |
| Forward P/E Ratio Valuation | 18.9x | 28.8x | Lower Multiple | ARDX |
| Revenue Growth (YoY) Growth | +15.7% | +54.9% | Higher Growth | AVDL |
| Operating Margin (TTM) Profitability | -7.7% | 2.5% | Higher Margin | AVDL |
| Net Profit Margin Profitability | -11.8% | -0.1% | Higher Margin | AVDL |
| Return on Equity (ROE) Capital Efficiency | -34.8% | -0.3% | Higher ROE | AVDL |
| 52-Week Range Position Momentum | 3% ($3โ$8) | 89% ($6โ$24) | Stronger Trend | AVDL |
| Beta / 30D Volatility Risk Regime | 0.93ฮฒ ยท 56% Vol | 0.14ฮฒ ยท 2% Vol | Lower Realized Risk | AVDL |
| Unified Institutional Score Composite Signal | 57.7 / 100 (HOLD) | 62.9 / 100 (BUY) | Higher Composite | AVDL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ARDX vs AVDL Buy Guide
ARDX
BREAKDOWN
140d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
14th %ile
IV Regime
Compressed (<25th %ile)
AVDL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ARDX nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.